Biotech · Private company · Bloomington, IN, US
Door Pharmaceuticals, LLC
Track this companyFree. Adds Door Pharmaceuticals, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- Advancing HBV antivirals that suppress viral replication and HBsAg productionFiscal year 2026 · $314.4KNIH RePORTER 1R43AI195101-01 · fetched Nov 12, 2026
- A new class of antiviral directed at HBV capsid proteinFiscal year 2024 · $306.5KNIH RePORTER 1R43AI181057-01 · fetched Nov 12, 2026